Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. – Cost Effective Supplements

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/12888186

Conclusion of this study

Patients in the omega-3 PUFA group had a significantly decreased score on the 21-item Hamilton Rating Scale for Depression than those in the placebo group (P < 0.001). From the preliminary findings in this study, omega-3 PUFAs could improve the short-term course of illness and were well tolerated in patients with major depressive disorder.